Remimazolam
Remimazolam
Definition
A short-acting benzodiazepine derivative that is structurally related to midazolam, with sedative-hypnotic activity. Upon administration, remimazolam targets and binds to a specific site on the gamma-aminobutyric acid (GABA)-A-chloride ionophore receptor complex located on the neuronal membrane. Binding causes an allosteric modification of the receptor thereby enhancing the affinity of GABA to the receptor leading to an increase in the frequency of chloride-channel opening events, which leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential, and a decrease in neuronal excitability.
Also known as CNS 7056, CNS-7056, CNS7056, REMIMAZOLAM — per NCIT
Also identified as
- ATC N05CD14 per RXNORM
- NCIT NCIT:C152187 per NCIT
- SCTID 926369003 per RXNORM
- SCTID 926383001 per RXNORM
- UNII 7V4A8U16MB per RXNORM